Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: Correlation with tumor parameters and disease activity

Cancer

Volumn 82, Issue 3, 1998, Pages 576-582

  Lazzarino, M ^a   Orlandi, E ^a   Klersy, C ^a   Astori, C ^a   Brusamolino, E ^a   Corso, A ^a   Bellio, L ^a   Gargantini, L ^a   Morra, E ^a   Bernasconi, C ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

CA 125; Non Hodgkin's lymphoma; Serum markers; Staging

Indexed keywords

BETA 2 MICROGLOBULIN; CA 125 ANTIGEN; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; CA-125 ANTIGEN; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PERICARDIAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; REMISSION INDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0032006997     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980201)82:3<576::AID-CNCR21>3.0.CO;2-Y     Document Type: Article

References (13)